Documentos relacionados

1. Late onset neuromyelitis optica spectrum disorder with anti-aquaporin 4 and anti-myelin oligodendrocyte glycoprotein antibodies.
2. Renal dysfunction in AQP4 NMOSD and MS; a potential predictor of relapse and prognosis.
3. Anti-aquaporin-4 immunoglobulin G colorimetric detection by silver nanoparticles.
4. Distinct features of B cell receptors in neuromyelitis optica spectrum disorder among CNS inflammatory demyelinating diseases.
5. [From neuromyelitis optica to neuromyelitis optica spectrum disorder: from clinical syndrome to diagnistic classification].
6. Should Aquaporin-4 Antibody Test Be Performed in all Patients With Isolated Optic Neuritis?
7. Lack of association between unipolar or bipolar depression and serum aquaporin-4 autoantibodies.
8. Time to Disability Milestones and Annualized Relapse Rates in NMOSD and MOGAD.
9. Time-Dependent Analysis of Sicca Symptoms and Anti-Ro/SSA and Anti-La/SSB Antibodies in Patients with AQP4-IgG-Positive Neuromyelitis Optica Spectrum Disorder.
10. Establishment of a comprehensive diagnostic model for neuromyelitis optica spectrum disorders based on the analysis of laboratory indicators and clinical data.